Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 31 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

32%

10 trials in Phase 3/4

Results Transparency

6%

1 of 17 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

25Total
Not Applicable (14)
P 2 (1)
P 3 (3)
P 4 (7)

Trial Status

Completed17
Not Yet Recruiting4
Unknown4
Recruiting3
Withdrawn2
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 17 completed trials

Clinical Trials (31)

Showing 20 of 20 trials
NCT04731025Phase 3Recruiting

Local Antibiotics for Breast Implants

NCT05699174Phase 3Recruiting

PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation

NCT05329701Phase 4Completed

Individualized Duration of Antibiotic Treatment in Early Onset Infection in Newborns.

NCT03935828Phase 2Withdrawn

Effect of Topical Sinonasal Antibiotics

NCT05499481Phase 3Completed

Short Against Long Antibiotic Therapy for Infected Orthopedic Sites

NCT04081792Not ApplicableCompleted

Optimal Antibiotics for Operated Diabetic Foot Infections

NCT05950984Completed

Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK)

NCT06850714Not ApplicableNot Yet RecruitingPrimary

Evaluation of Bifidobacterium Breve PRL2020 in Preventing Antibiotic-Associated Side Effects From Amoxicillin or Amoxicillin/Clavulanic Acid

NCT06672471Not ApplicableEnrolling By Invitation

Post-Operative Antibiotic Efficacy in Clean Contaminated Head and Neck Surgery: A Randomized Controlled Trial

NCT05355571Not ApplicableCompletedPrimary

The Impact of Probiotic Supplementation on Antibiotic Induced Changes in Gastrointestinal Function And/or Faecal Microbiota Composition

NCT06395454Not ApplicableNot Yet RecruitingPrimary

Usage of Procalcitonin to Reduce Antibiotics Duration in VAP in Neurosurgical ICU

NCT03305627Not ApplicableCompleted

Optimized Perioperative Antibiotic Prophylaxis in Radical Cystectomy

NCT06383637Not Yet RecruitingPrimary

Antibiotic Use and Resistance KAP Among Dental Interns

NCT06018792Recruiting

Molecular Culture for the Diagnosis of Pediatric Sepsis

NCT06250413Not ApplicableNot Yet Recruiting

Autoflor -Lyophilized Capsulated Autological FMT to Restore Gut Microbiome After Treatment With Antibiotics

NCT03001167Completed

Microbiome, Antibiotics, and Growth Infant Cohort

NCT05742295Phase 4CompletedPrimary

Prevention of Cefoperazone-induced Coagulopathy

NCT06030713Not ApplicableCompleted

Timing of Maternal Antibiotic Prophylaxis During a Cesarean Section and the Early Infant Gut Microbiome

NCT05974657Not ApplicableCompletedPrimary

Effectiveness and Safety of Lactobacillus Acidophilus LA85 in Preventing Antibiotic-Associated Diarrhea

NCT04620629CompletedPrimary

The Effect of Probiotic Supplement on Urinary D-lactic Acid Level in Newborns

Scroll to load more

Research Network

Activity Timeline